Astellas Boosts Eye Disease Platform with Quethera

16.08.2018 - Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. The acquisition...